Dragan Cicic
Senior VP & Chief Development OfficerDr. Dragan Cicic, M.D., MBA serves as Senior Vice President, Chief Development Officer at SELLAS Life Sciences Group, Inc. since January 2024 and served as its Senior Vice President of Clinical Development since February 2, 2020 until December 2023. He was a Senior Vice President, Clinical Lead, at Klus Pharma, a wholly owned U.S. subsidiary of Kelun, a major China-based multinational pharmaceutical company with about 30,000 employees worldwide. At Klus Pharma, Dr. Cicic led the global clinical development of targeted solid cancer biologicals and was involved in the development of novel checkpoint inhibitors as well as other innovative biological and small molecule drug candidates He served as the Chief Technology Officer of Actinium Pharmaceuticals, Inc. from January 18, 2017 to May 12, 2017. Prior to Klus Pharma, Dr. Cicic served as the Chief Medical Officer of Actinium Pharmaceuticals, Inc. since August 28, 2012 until January 18, 2017. Dr. Cicic served as the Chief Executive Officer and President of Actinium Pharmaceuticals, Inc. until August 2012 and served as its Medical Director, Chief Operating Officer and Vice President. He joined Actinium Pharmaceuticals in 2005. He served as the Project Director of QED Technologies Inc. Dr. Cicic prepared business and strategic plans on behalf of those clients and assisted them in raising funding. He also represented corporate and private investors in identifying acquisition and/or investment targets and negotiating, structuring and consummating deals. He worked in a number of health care related roles, ranging from that of a Physician to Health Care Investment Banker to Strategic Life Sciences Consultant. Prior to joining QED Technologies, he was an Investment Banker with SG Cowen Securities, a New York subsidiary of Societé General. At SG Cowen, he specialized in Health Care Mergers and Acquisitions. He worked with some of the most advanced US and Canadian biotechnology and medical technology companies. He worked on strategic planning and business combinations and participated in execution of deals. Before joining SG Cowen, Dr. Cicic worked in a business development role for various media organizations. Prior to that, Dr. Cicic worked with a number of media organizations, including BBC and London Times. He started his career as a Medical Doctor in Yugoslavia. He serves as a Director of Actinium Pharmaceuticals Inc. Dr. Cicic has published extensively in the fields of hematologic malignancies and solid cancers. He is a member of the American Society of Hematology.He was a Nieman Fellow at Harvard University. Dr. Cicic graduated as a Medical Doctor from the School of Medicine from the University of Belgrade and received his MBA from Wharton School at The University of Pennsylvania.
Positions
- Company NameSELLAS Life Sciences Group, Inc.Stock CodeSLSPositionSenior VP & Chief Development OfficerColleagues
- AMAngelos M. StergiouFounder, President, CEO & Director
- JWJohn W. VarianIndependent Chairman of Board
- JTJohn Thomas BurnsSenior VP & CFO
- SEStacy E. YeungVP, General Counsel & Corporate Secretary
- AEAndrew ElnatanSenior VP of Regulatory Affairs, CMC & Quality
- JWJane WasmanIndependent Director
- RLRobert L. Van NostrandIndependent Director
- KBKatherine Bach KalinIndependent Director
